There was no significant effect on the overall (Fig. 4A) or individual (SI Appendix, Fig. S6 B and C) frequencies of influenza- and myelin-specific CD8+ T cells following anti-CD20 mAb treatment, with the exception of a small reduction in M158–66-specific CD8+ T cells (SI Appendix, Fig. S6B). The gene discussed is CD8A; the disease is influenza.